ASP receives FDA emergency use authorization to decontaminate N95 respirators
Apr 13, 2020
Advanced Sterilization Products Granted Emergency Use Authorization by FDA
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Advanced Sterilization Products (ASP) for its STERRAD Sterilization Cycles to decontaminate millions of N95 respirators.
The STERRAD Sterilization Cycles, which uses vaporized hydrogen peroxide gas plasma sterilization, includes STERRAD 100S Cycle, STERRAD NX Standard Cycle, and STERRAD 100NX Express Cycle.
These sterilization cycles differ in reprocessing times from 55 minutes, to 28 minutes, and 24 minutes. Each is capable of reprocessing almost 480 respirators on a daily basis.